AzTrials
AzTrials

FibromyalgiaBATBFNCT05555394

Body Awareness Therapy and Biomarkers in Fibromyalgia

A study testing Basic Body Awareness Therapy and Stretching Exercise in people with Fibromyalgia, run by Universitat de Lleida at 2 sites in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

A randomized trial of Basic Body Awareness Therapy (BBAT) is applied in fibromyalgia patients as compared with a control intervention consisting of stretching. Sessions of BBAT lasted 90 min each and took place twice a week form 12 weeks. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Fibromyalgia
What is being tested?
Basic Body Awareness Therapy and Stretching Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
2 sitesSpain
Study dates
8 May 2024to 1 Sep 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • whose diagnosed of fibromyalgia almost 6 months before
  • whose could be in different position such as lying, sitting, and stand-up

Who cannot join

  • whose are diagnosed of disease that it worse the pain
  • pregnancy
  • whose are diagnosed of other disease such as rheumatology, neurology, cardiac problems o another internal medical condition,malignant disease or acute infections

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Cristina Bravo, PhD contact

+34 656312125

cristina.bravo@udl.cat

Spain2 sites, 2 recruiting
  • Consorci Sanitari de l'Anoia

    Igualada, Barcelona, 08700

    Aurora Garriga, Dr, +34 8075800, agarriga@csa.cat

    Cristina Bravo, Pt

    Recruiting
  • Cristina Bravo Navarro

    Igualada, Barcelona, 08700

    Cristina Bravo Navarro, 656312125, cristinabn@gmail.com

    Recruiting

Other trials in Spain

About this study

Official title: Effectiveness of a Rehabilitation Programme Based on Lifestyle Changes and Self-care in Patients Diagnosed With Fibromyalgia: Neuroinflammatory and Neuropsychological Biomarkers.

A randomized trial of Basic Body Awareness Therapy (BBAT) is applied in fibromyalgia patients as compared with a control intervention consisting of stretching. Sessions of BBAT lasted 90 min each and took place twice a week form 12 weeks. The primary end point is a change in the biomarkers and neurotransmitters and the Fibromyalgia Impact Questionnaire and the secondary end points include Visual Analog Scale, State Trait Anxiety inventory, Beck Depression Inventory. All assessments will be repeated at post treatment, 12 and 24 weeks and 1 year follow-up.

Read the detailed description

This work is a clinical trial of randomized and controlled groups. The hypothesis of study is that BBAT applied in patients with fibromyalgia improves, more than stretching exercises, the pain, normalization biomarkers, improve in psychological state and quality life.

The study population will be selected followed the inclusion criteria of fibromyalgia, and will be selected in Consorci Sociosanitari of Anoia, the patients will be divided in 2 groups, control and treatment group. The groups will be examined at the begin, at 2 weeks, at the end of treatment and 3, 6 and 12 months follow-up.

The dependence measurements will be biomarkers serotonin, dopamine and cortisol, also Visual Analog Scale, State Trait Anxiety Inventory (STAI A/R), Beck Depression Inventory (BDI-II) and Fibromyalgia Impact Questionnaire (FIQ). The independence measurements will be demographic items: sex, age, country, level of studies, social status...

Conditions
Fibromyalgia
Being tested
Basic Body Awareness Therapy, Stretching Exercise
Keywords
Body awareness therapy, physical therapy, serotonin, cortisol
Medical subject headings
Fibromyalgia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Basic Body Awareness TherapyOther

    Also called BBAT

    The intervention will be twice a week during 12 weeks. It lasts 90 min of movements of daily life, massage and self-reflections.

  • Stretching ExerciseOther

    It consists in stretching movements of whole body

Study groups in NCT05555394
Study groupRoleWhat they receive
Basic Body Awareness TherapyExperimentalthe Basic Body Awareness Therapy is usual therapy of physiotherapy in mental health in nord europe. BBAT is based in twelve movements and massage that improve the movements quality of patient, also improves other movement qualities like biomechanical, physiologic, socio-cultural and existential
Receives: Other: Basic Body Awareness Therapy
Stretching groupActive comparatorStretching exercise will be developed in control group in order to blind the intervention of interest. It will consist in analytic stretching of trunk, upper and lower limb. It will last around 45 min twice a week during 12 weeks.
Receives: Other: Stretching Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Serotonin

    Neurotransmitter neurologic

    Measured: through study completion, an average of 1 year

  2. cortisol

    acute hormone relating stress

    Measured: during the procedure

Secondary outcomes (4)
  1. Visual Analog Scale (VAS)

    Assess of subjective pain of patient. It consists in a number between 0 to 10

    Measured: through study completion, an average of 1 year

  2. Fibromyalgia Impact Questionnaire (FIQ)

    Questionnaire about the impact of symptoms of Fibromyalgia in daily life. It measures 21 items with a total score between 0 to 100. The main average is 50.

    Measured: through study completion, an average of 1 year

  3. Beck Depression Inventory- II (BDI-II)

    Questionnaire for assess the depression of patient. It consists in 21 items with scale ranking from 0-3 with a total score from 0-63. A score between 10-18 corresponds to mild to moderate depression, further than 30 corresponds to severe depression

    Measured: through study completion, an average of 1 year

  4. State Trait Anxiety Inventory (STAI)

    Questionnaire for assess the anxiety of patient. It consists in 20 questions that score range from 20 to 80. The higher scores correlating with greater anxiety. The questionnaire provide information about state (how a person is feeling at the time) and trait (how people feel across typical situations that everyone experiences on a daily basis)

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Sep 2022
  2. Study start8 May 2024
  3. Primary completion1 May 2025 (estimated)
  4. Study completion1 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
clinical trial randomized allocated controlled
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05555394
Sponsor's protocol ID
04 University of Lleida
Acronym
BATBF
Status last verified
May 2025
First submitted
14 Sep 2022
Last updated
8 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Busch AJ, Webber SC, Brachaniec M, Bidonde J, Bello-Haas VD, Danyliw AD, Overend TJ, Richards RS, Sawant A, Schachter CL. Exercise therapy for fibromyalgia. Curr Pain Headache Rep. 2011 Oct;15(5):358-67. doi: 10.1007/s11916-011-0214-2.

    PubMed 21725900
  • Atasever M, Namli Kalem M, Sonmez C, Seval MM, Yuce T, Sahin Aker S, Koc A, Genc H. Lower serotonin level and higher rate of fibromyalgia syndrome with advancing pregnancy. J Matern Fetal Neonatal Med. 2017 Sep;30(18):2204-2211. doi: 10.1080/14767058.2016.1243096. Epub 2016 Nov 29.

    PubMed 27696917
  • Bravo C, Skjaerven LH, Espart A, Guitard Sein-Echaluce L, Catalan-Matamoros D. Basic Body Awareness Therapy in patients suffering from fibromyalgia: A randomized clinical trial. Physiother Theory Pract. 2019 Oct;35(10):919-929. doi: 10.1080/09593985.2018.1467520. Epub 2018 May 3.

    PubMed 29723080
  • Bravo C, Skjaerven LH, Guitard Sein-Echaluce L, Catalan-Matamoros D. Effectiveness of movement and body awareness therapies in patients with fibromyalgia: a systematic review and meta-analysis. Eur J Phys Rehabil Med. 2019 Oct;55(5):646-657. doi: 10.23736/S1973-9087.19.05291-2. Epub 2019 May 15.

    PubMed 31106558
  • Coppieters I, Cagnie B, Nijs J, van Oosterwijck J, Danneels L, De Pauw R, Meeus M. Effects of Stress and Relaxation on Central Pain Modulation in Chronic Whiplash and Fibromyalgia Patients Compared to Healthy Controls. Pain Physician. 2016 Mar;19(3):119-30.

    PubMed 27008285

Questions about this trial

What is this clinical trial studying?

A study testing Basic Body Awareness Therapy and Stretching Exercise in people with Fibromyalgia, run by Universitat de Lleida at 2 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Cristina Bravo, PhD (+34 656312125, cristina.bravo@udl.cat), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Serotonin (time frame: through study completion, an average of 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05555394, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in